Purpose. To identify whether the serum's baseline @entity1851 ( @entity1851 ) and @entity2313 ( @entity2313 ) levels related to clinicopathological parameters and overall survival (OS) in @entity1149 ( @entity1149 ). Methods. In total, 100 consecutive @entity1 (mean age = 68.38    10.85 years) that underwent chemoradiotherapy were studied. Measurements of @entity1851 and @entity2313 were performed before any treatment. Results. Serum @entity1851 levels were significantly associated with histological grade (P < 0.001), @entity2802 stage (P < 0.001), PS (P = 0.009), and @entity2313 (P < 0.001). Additionally @entity1851 and @entity2313 levels were found significantly associated with overall survival in univariate analysis (log-rank test, P < 0.001 and P = 0.002, resp.) and @entity1851 remained significant after controlling for age, @entity285 , performance status, and @entity2802 stage, whereas @entity2313 showed a borderline effect on the hazard rate (P = 0.052). Conclusions. @entity1851 and @entity2313 are both promising biomarkers in identification of @entity1149 @entity1 with poor prognosis and form a possible target for intensifying their therapies.

Prognostic Significance of Serum Inflammatory Response Markers in Newly Diagnosed XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity2313 :: ('213', 'Gene') :: ['albumin', 'Alb'] @entity1149 :: ('MESH:D002289', 'Disease') :: ['NSCLC', 'non-small cell lung cancer'] @entity2802 :: ('10178', 'Gene') :: ['TNM'] @entity285 :: ('D000431', 'Chemical') :: ['alcohol'] @entity1851 :: ('1401', 'Gene') :: ['C-reactive protein', 'CRP']
@entity1149 :: (MESH:D002289,Disease) :: ['Non-Small Cell Lung Cancer before Chemoirradiation']
